CareTrust REIT (CTRE) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
24 Mar, 2026Executive summary
Achieved record capital deployment of $1.76B and 17% year-over-year normalized FFO per share growth in 2025.
Market capitalization grew to over $8.3B, up from $5.1B in 2024 and $2.9B in 2023.
Expanded internationally into the U.K. and established a senior housing operating platform.
Delivered a 10-year total return of 493%, leading U.S. healthcare REITs.
Voting matters and shareholder proposals
Board requests support for the advisory vote to approve executive compensation (say-on-pay) at the 2026 Annual Meeting.
Board of directors and corporate governance
Board engaged with shareholders representing 73% of shares, with 57% participating in engagement or confirming no meeting was needed.
Compensation committee chair participated in all engagement meetings.
Partial view of Summaries dataset, powered by Quartr API
Latest events from CareTrust REIT
- Proxy seeks approval for director elections, executive pay, and auditor ratification after a record growth year.CTRE
Proxy Filing13 Mar 2026 - Definitive proxy statement outlines annual meeting proposals and confirms board oversight.CTRE
Proxy Filing13 Mar 2026 - Record 2025 growth and robust 2026 outlook with strong FFO, FAD, and pipeline momentum.CTRE
Q4 20254 Mar 2026 - Double-digit FFO growth, robust investments, and industry-leading returns drive shareholder value.CTRE
Investor presentation2 Mar 2026 - Q2 2024 saw record investments, robust growth, and historic low leverage with strong liquidity.CTRE
Q2 20242 Feb 2026 - Q3 2024 net income hit $33.4M, with record investments and a robust pipeline.CTRE
Q3 202417 Jan 2026 - $817M acquisition of 137 U.K. care homes brings accretion, diversification, and growth.CTRE
M&A Announcement25 Dec 2025 - Q1 2025 saw record earnings, a dividend hike, and a major UK acquisition set to close.CTRE
Q1 202523 Dec 2025 - Record investments and double-digit FFO growth projected for 2025 with low leverage.CTRE
Q4 202419 Dec 2025